TRENTON, N.J. (AP) - Cancer drugs predictably cost much more in the U.S. than in poor countries and even other wealthy nations, but a study shows they are less affordable in some developing countries despite the lower price.
Relative to their ability to pay, cancer patients in China and India face much higher prices than wealthier U.
Study: Cancer drugs less affordable in poor nations than US
Aucun commentaire:
Enregistrer un commentaire